Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2013 Feb 01;1684:954-65. doi: 10.1111/j.1476-5381.2012.02221.x.
Show Gene links
Show Anatomy links
Positive modulation of the α9α10 nicotinic cholinergic receptor by ascorbic acid.
Boffi JC
,
Wedemeyer C
,
Lipovsek M
,
Katz E
,
Calvo DJ
,
Elgoyhen AB
.
???displayArticle.abstract???
The activation of α9α10 nicotinic cholinergic receptors (nAChRs) present at the synapse between efferent olivocochlear fibres and cochlear hair cells can prevent acoustic trauma. Hence, pharmacological potentiators of these receptors could be useful therapeutically. In this work, we characterize ascorbic acid as a positive modulator of recombinant α9α10 nAChRs. ACh-evoked responses were analysed under two-electrode voltage-clamp recordings in Xenopus laevis oocytes injected with α9 and α10 cRNAs. Ascorbic acid potentiated ACh responses in X. laevis oocytes expressing α9α10 (but not α4β2 or α7) nAChRs, in a concentration-dependent manner, with an effective concentration range of 1-30 mM. The compound did not affect the receptor's current-voltage profile nor its apparent affinity for ACh, but it significantly enhanced the maximal evoked currents (percentage of ACh maximal response, 240 ± 20%). This effect was specific for the L form of reduced ascorbic acid. Substitution of the extracellular cysteine residues present in loop C of the ACh binding site did not affect the potentiation. Ascorbic acid turned into a partial agonist of α9α10 nAChRs bearing a point mutation at the pore domain of the channel (TM2 V13'T mutant). A positive allosteric mechanism of action rather than an antioxidant effect of ascorbic acid is proposed. The present work describes one of the few agents that activates or potentiates α9α10 nAChRs and leads to new avenues for designing drugs with potential therapeutic use in inner ear disorders.
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011, Pubmed
Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011,
Pubmed
Amato,
Modulation of neuronal and recombinant GABAA receptors by redox reagents.
1999,
Pubmed
Arias,
Positive and negative modulation of nicotinic receptors.
2010,
Pubmed
Arias,
Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
2011,
Pubmed
Ballestero,
Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptors.
2005,
Pubmed
,
Xenbase
Bartos,
Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region.
2009,
Pubmed
Bateson,
The benzodiazepine site of the GABAA receptor: an old target with new potential?
2004,
Pubmed
Bertrand,
Allosteric modulation of nicotinic acetylcholine receptors.
2007,
Pubmed
Bertrand,
Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment.
2008,
Pubmed
,
Xenbase
Bigelow,
Gamma-aminobutyric acid stimulates the release of endogenous ascorbic acid from rat striatal tissue.
1984,
Pubmed
Bouzat,
Changes in channel properties of acetylcholine receptors during the time course of thiol chemical modifications.
1991,
Pubmed
Burmeister,
High resolution X-ray crystallography shows that ascorbate is a cofactor for myrosinase and substitutes for the function of the catalytic base.
2000,
Pubmed
Calero,
Redox modulation of homomeric rho1 GABA receptors.
2008,
Pubmed
,
Xenbase
Calero,
Allosteric modulation of retinal GABA receptors by ascorbic acid.
2011,
Pubmed
,
Xenbase
Chu,
ASIC1a-specific modulation of acid-sensing ion channels in mouse cortical neurons by redox reagents.
2006,
Pubmed
Corti,
Cellular pathways for transport and efflux of ascorbate and dehydroascorbate.
2010,
Pubmed
Dunckley,
Mutational analysis of roles for extracellular cysteine residues in the assembly and function of human alpha 7-nicotinic acetylcholine receptors.
2003,
Pubmed
Dyer,
Expression of a rabbit renal ascorbic acid transporter in Xenopus laevis oocytes.
1994,
Pubmed
,
Xenbase
Elgoyhen,
The nicotinic receptor of cochlear hair cells: a possible pharmacotherapeutic target?
2009,
Pubmed
Elgoyhen,
The efferent medial olivocochlear-hair cell synapse.
2012,
Pubmed
Elgoyhen,
alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.
2001,
Pubmed
,
Xenbase
Ellison,
Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.
2006,
Pubmed
,
Xenbase
Evans,
The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration.
1982,
Pubmed
Gill,
Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
2011,
Pubmed
,
Xenbase
Grünewald,
Ascorbic acid in the brain.
1993,
Pubmed
Harrison,
Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.
2009,
Pubmed
Hediger,
New view at C.
2002,
Pubmed
Heinrich,
Ascorbic acid reduces noise-induced nitric oxide production in the guinea pig ear.
2008,
Pubmed
Iorga,
Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach.
2006,
Pubmed
Johnson,
alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
1995,
Pubmed
,
Xenbase
Klomsiri,
Cysteine-based redox switches in enzymes.
2011,
Pubmed
Labarca,
Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors.
1995,
Pubmed
,
Xenbase
Landino,
Ascorbic acid reduction of microtubule protein disulfides and its relevance to protein S-nitrosylation assays.
2006,
Pubmed
Le Prell,
Free radical scavengers vitamins A, C, and E plus magnesium reduce noise trauma.
2007,
Pubmed
Leprince,
Chemical modification of the nicotinic cholinergic receptor of PC-12 nerve cell.
1983,
Pubmed
Lioudyno,
The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear.
2002,
Pubmed
,
Xenbase
Lynch,
Compounds for the prevention and treatment of noise-induced hearing loss.
2005,
Pubmed
MONOD,
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
1965,
Pubmed
Maison,
Efferent protection from acoustic injury is mediated via alpha9 nicotinic acetylcholine receptors on outer hair cells.
2002,
Pubmed
Majewska,
Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate.
1990,
Pubmed
McFadden,
Dietary vitamin C supplementation reduces noise-induced hearing loss in guinea pigs.
2005,
Pubmed
McGrath,
Guidelines for reporting experiments involving animals: the ARRIVE guidelines.
2010,
Pubmed
McIntosh,
A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
2005,
Pubmed
,
Xenbase
Miele,
In vivo determination of extracellular brain ascorbate.
1996,
Pubmed
Mishra,
Polysaccharide binding sites in hyaluronate lyase--crystal structures of native phage-encoded hyaluronate lyase and its complexes with ascorbic acid and lactose.
2009,
Pubmed
Nelson,
Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate.
2007,
Pubmed
Pan,
Redox modulation of recombinant human GABA(A) receptors.
2000,
Pubmed
,
Xenbase
Pande,
The arginines of cytochrome c. The reduction-binding site for 2,3-butanedione and ascorbate.
1980,
Pubmed
Plazas,
Key roles of hydrophobic rings of TM2 in gating of the alpha9alpha10 nicotinic cholinergic receptor.
2005,
Pubmed
,
Xenbase
Plazas,
Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor.
2005,
Pubmed
,
Xenbase
Plazas,
Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.
2007,
Pubmed
,
Xenbase
Portugal,
Glutamate receptors modulate sodium-dependent and calcium-independent vitamin C bidirectional transport in cultured avian retinal cells.
2009,
Pubmed
Rebec,
A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.
1994,
Pubmed
Reiber,
Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate.
1993,
Pubmed
Rice,
Differential compartmentalization of brain ascorbate and glutathione between neurons and glia.
1998,
Pubmed
Rice,
Ascorbate regulation and its neuroprotective role in the brain.
2000,
Pubmed
Rose,
Ocular ascorbate transport and metabolism.
1991,
Pubmed
Rothlin,
The alpha9 nicotinic acetylcholine receptor shares pharmacological properties with type A gamma-aminobutyric acid, glycine, and type 3 serotonin receptors.
1999,
Pubmed
,
Xenbase
Rothlin,
Block of the alpha9 nicotinic receptor by ototoxic aminoglycosides.
2000,
Pubmed
,
Xenbase
Rothlin,
Direct interaction of serotonin type 3 receptor ligands with recombinant and native alpha 9 alpha 10-containing nicotinic cholinergic receptors.
2003,
Pubmed
,
Xenbase
Ruiz-Gómez,
Sulfhydryl groups modulate the allosteric interaction between glycine binding sites at the inhibitory glycine receptor.
1991,
Pubmed
Ruppersberg,
Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation.
1991,
Pubmed
,
Xenbase
Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed
Sharp,
Crystal structure of the ascorbate peroxidase-ascorbate complex.
2003,
Pubmed
Spector,
Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy.
2006,
Pubmed
Stitzel,
Sulfhydryl modification of two nicotinic binding sites in mouse brain.
1988,
Pubmed
Sullivan,
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor.
1994,
Pubmed
,
Xenbase
Taranda,
A point mutation in the hair cell nicotinic cholinergic receptor prolongs cochlear inhibition and enhances noise protection.
2009,
Pubmed
Thompson,
The structural basis of function in Cys-loop receptors.
2010,
Pubmed
Verbitsky,
Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor.
2000,
Pubmed
,
Xenbase
Vio,
Hearing loss and tinnitus: 250 million people and a US$10 billion potential market.
2005,
Pubmed
Young,
Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
2008,
Pubmed
,
Xenbase
Zorrilla de San Martín,
Ryanodine is a positive modulator of acetylcholine receptor gating in cochlear hair cells.
2007,
Pubmed
,
Xenbase
